1,958 hedge funds and large institutions have $144B invested in Pfizer in 2016 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 884 increasing their positions, 762 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less first-time investments, than exits

New positions opened: | Existing positions closed:

1% less funds holding

Funds holding: 1,9871,958 (-29)

5% less capital invested

Capital invested by funds: $152B → $144B (-$8.2B)

18% less funds holding in top 10

Funds holding in top 10: 285234 (-51)

Holders
1,958
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
234
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.25B
Puts
$2.33B
Net Calls
Net Calls Change

Top Buyers

1 +$337M
2 +$327M
3 +$270M
4
Renaissance Technologies
Renaissance Technologies
New York
+$231M
5
JP Morgan Chase
JP Morgan Chase
New York
+$176M
Name Holding Trade Value Shares
Change
Change in
Stake
1601
$548K
1602
$539K
1603
$536K
1604
$536K
1605
$533K
1606
$532K
1607
$528K
1608
$527K
1609
$525K
1610
$524K
1611
$524K
1612
$521K
1613
$520K
1614
$517K
1615
$517K
1616
$513K
1617
$511K
1618
$510K
1619
$508K
1620
$503K
1621
$498K
1622
$495K
1623
$495K
1624
$494K
1625
$493K